Skip to main content

Table 2 Exercise capacities of the patients according to their baseline characteristics (n = 71)

From: Real-life feasibility of home-based pulmonary rehabilitation in chemotherapy-treated patients with thoracic cancers: a pilot study

  6MWT distance (m) 6MST steps (nb) TUG time (s) 10CS time (s)
All evaluated patients together 390 [290–450] 466 [297–572] 9 [7–14] 31 [25–47]
Lung cancer stage
 stage II 440 [395–493] 496 [412–516] 13 [11–14] 43 [27–59]
 stage III 393 [323–433] 482 [372–578] 6 [5–8] 25 [25–25]
 stage IV 342 [260–460] 441 [271–552] 10 [8–15] 36 [27–54]
MPM 445 [420–510] 479 [337–582] 8 [7–9] 24 [21–33]
WHO performance status     
 stage 0 (n = 24) 430 [385–463] 516 [455–596] 6 [6–12] 23 [18–28]
 stage 1 (n = 25) 358 [285–440] 468 [292–572] 9 [7–14] 31 [24–50]
 stage 2 (n = 21) 290 [240–420] 282 [148–404] 9 [8–15] 36 [27–47]
mMRC dyspnea stage
 stage 0 (n = 4) 460 [448–473] 672 [575–676] NA NA
 stage 1 (n = 26) 430 [358–470] 496 [408–579] 8 [7–10] 25 [21–29]
 stage 2 (n = 17) 368 [250–435] 542 [466–606] 9 [6–11] 30 [19–40]
 stage 3 (n = 9) 285 [240–290] 251 [150–276] 10 [9–14] 39 [31–48]
 stage 4 (n = 5) 275 [170–380] 132 [71–303] 16 [11–23] 54 [38–59]
  1. Results are given as medians with interquartile ranges. 6MWT 6-min walk test distance, 6MST 6-min stepper test, TUG: timed Up and Go test, 10CS: ten chair stands [10,11,12,13], MPM malignant pleural mesothelioma, WHO World Health Organization, mMRC modified Medical Research Council dyspnea scale, NA not available